Save 10% off on your first order with coupon code: FIRST

Apidra Vials (Insulin Glulisine)

Apidra VialsGENERICBRAND

100u/mL

Prescription Required. Product of Canada. Shipped from Canada. Sourced from Canada

Prescription Required. Product of United Kingdom. Shipped from United Kingdom. Sourced from United Kingdom

This is a refrigerated product. A flat rate of $29.99 express shipping fee will be applied to your order. This product will be shipped out in an insulated styrofoam container with gel and ice packs inside. Parcels are shipped via Canada Post Express.

See what our customers have to say about their purchase!

0 0 votes
Rating

Free with your purchase:

Purchase
Guarantee

Lowest Price
Guarantee

Identity Theft
Guarantee

Satisfaction Guarantee

A 30 day guarantee of up to a $1,000 of the purchase price, that you will receive the products/services you ordered, in accordance with the terms of sale.

Price Protection Guarantee

If the store's published price drops within 30 days of the purchase, you can make a claim for up to $100 of the difference.

ID Recovery Assistance

Provides help in the event of identity theft for up to 30 days after a sale, to help allay concerns about the security of your personal information. Up to total of $10,000 worth of specialist services.

Product Information

What is Apidra Vial?

Apidra is an insulin glulisine manufactured by Sanofi-Aventis. Apidra vial is made from a non-pathogenic strain of escherichia coli and differs from human insulin by substitution of lysine instead of aspargine in the B3 and glutamic acid instead of lysine at the B29 position.

Apidra vial contains 10mL or 1000 units each vial. It is made in colorless glass with an aluminum cap, tear-off lid, and inserted rubber gasket.

How to Take It?

Apidra vials can be used to refill external insulin infusion pumps. It should be taken subcutaneously 15 minutes before meals or within 20 minutes after meals. Rotation of the site of administration should be applied between the abdomen, thighs, and upper arms to avoid skin irritation. Injection in the abdomen is slightly faster to effect than the other sites and make sure to avoid muscles and veins. Apidra is a “bolus insulin” as it gives the patients high levels of insulin in a short period of time and it can be sometimes administered with a long-acting “basal-insulin” like insulin glargine, insulin detemir, and insulin degludac. The combination of basal and bolus insulin is often used to copy the production of endogenous insulin.

Dosage

The doctor will determine the correct dose for each patient who will be using the Apidra vial. The doctor will base this on the patient’s blood sugar tests and lifestyle.

Side Effects

Get medical help if the Apidra vial will cause shortness of breath, fast heartbeat, swelling of face and throat, and extreme drowsiness. Hypoglycemia or low blood sugar, hypokalemia or low potassium, severe allergic reaction, and heart failure are serious side effects that can lead the patient to death. Common side effects of Apidra vials are weight gain, itching, swelling, lipodystrophy (skin thickening), and hypoglycemia.

Warnings, Precautions, and Contraindications

Ensure that the patient is not allergic to insulin glulisine or any other ingredients of the Apidra vial. Closely monitor if the patient will have hypoglycemia. Let the physician know if the patient is pregnant, or has liver or kidney problems so the dose should be adjusted by the physician.

Adverse Effect

Apidra can cause seizures, brain damage, or unconsciousness in hypoglycemic patients. Hypokalemia may cause respiratory paralysis. Anaphylaxis is a life-threatening hypersensitivity reaction in patients.

Storage

Keep Apidra vial in a refrigerator below 77°F (25°C) and away from direct heat and light. Throw away opened vial after 28 days after the first use.

Campaign for Personal Prescription Importation

Millions of Americans use licensed Canadian pharmacies annually, to purchase their daily prescription medications at an affordable price. We believe that all Americans have a right to affordable medications.